Why is single use technology for biopharma booming?

  • Ryan Heffner, PE, Single Use Technology Manager

By Ryan Heffner

Ryan Heffner, PE, is manager of Equilibar’s new Single Use Technology division. He has spent much of his career focusing on fluid control for biopharmaceutical applications as well as trends in pharmaceutical manufacturing, including Pharma 4.0. He was instrumental in developing Equilibar’s single use SDO back pressure regulator, which received the 2022 Innovation Award from Pharma Manufacturing magazine. In this interview for the Equilibar blog, Ryan explains the advantages of Single Use Technology for pharmaceutical processes and how it plays a critical role in the implementation of Pharma 4.0.

Equilibar News
valve with pressure profile graph

Equilibar Introduces New Sanitary Pulsation Dampener for Biopharma Processes

Rated to 150 psig, the new device delivers clean, stable flow while remaining fully drainable and hygienic On July 28, Equilibar introduced its new Pulsation Dampener (PD) for biopharma processes.  Engineered to reduce pressure fluctuations caused by the action of positive displacement pumps and other process equipment, the PD meets the stringent hygienic requirements of Read More

Read More